EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?

Joanna Bartkowiak-Wieczorek iD, Edyta Mądry iD, Michał Książkiewicz, Jakub Winkler-Galicki iD, Milena Szalata iD, Marlena Szalata iD, Ulises Elizalde Jiménez iD, Karolina Wielgus iD, Edmund Grześkowiak, Ryszard Słomski iD, Agnieszka Bienert iD

Nutrients · 2023

DOI: 10.3390/nu15122646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Joanna Bartkowiak-Wieczorek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Department, Poznan University of Medical Sciences, ul. Święcickiego 6, 61-861 Poznań, Poland. Hauptthemen laut MEDLINE: Cannabinoids, Cannabis, Cannabidiol. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Centre for Research and Development, National Center for Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bioavailability levels of cannabidiol (CBD) and tetrahydrocannabinol (THC) determine their pharmacological effects. Therefore, for medical purposes, it is essential to obtain extracts containing the lowest possible content of the psychogenic component THC. In our extract, the CBD/THC ratio was 16:1, which is a high level compared to available medical preparations, where it is, on average, 1:1. This study assessed the bioavailability and stability of CBD and THC derived from Cannabis sativa L. with reduced THC content. The extract was orally administered (30 mg/kg) in two solvents, Rapae oleum and Cremophor, to forty-eight Wistar rats. The whole-blood and brain concentrations of CBD and THC were measured using liquid chromatography coupled with mass spectrometry detection. Much higher concentrations of CBD than THC were observed for both solvents in the whole-blood and brain after oral administration of the Cannabis sativa extract with a decreased THC content. The total bioavailability of both CBD and THC was higher for Rapae oleum compared to Cremophor. Some of the CBD was converted into THC in the body, which should be considered when using Cannabis sativa for medical purposes. The THC-reduced hemp extract in this study is a promising candidate for medical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsCannabisCannabidiolAnimalsRatsSolventsBiological AvailabilityRats, WistarPlant ExtractsPlant OilsPolyethylene Glycols

Stichwörter der Autor:innen

bioavailabilitycannabidiol (CBD)endocannabinoid systempharmacokineticstetrahydrocannabinol (THC)

Substanzen

CannabinoidsSolventsCannabidiolPlant ExtractsPlant OilscremophorPolyethylene Glycols

Autor:innen und Institutionen

  • Physiology Department, Poznan University of Medical Sciences, ul. Święcickiego 6, 61-861 Poznań, Poland.
  • Cannabitey s.c. Poznań, ul. Uniwersytetu Poznańskiego 10/B123, 61-614 Poznań, Poland.
  • Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants National Research Institute, Wojska Polskiego 71B, 60-630 Poznań, Poland.
  • Department of Biochemistry and Biotechnology, Poznań University of Life Sciences, ul. Dojazd 11, 60-632 Poznań, Poland.
  • Neuromed Consultorios, José Ibarra Olivares 106, Centro, Pachuca de Soto 42000, Hidalgo, Mexico.
  • Centro Médico Privado Sanatorio Ortega, José Ibarra Olivares 105, Centro, Pachuca de Soto 42000, Hidalgo, Mexico.

ORCID-Profile: Joanna Bartkowiak-Wieczorek, Edyta Mądry, Jakub Winkler-Galicki, Milena Szalata, Marlena Szalata, Ulises Elizalde Jiménez, Karolina Wielgus, Ryszard Słomski, Agnieszka Bienert

Förderung

  • The National Centre for Research and Development
  • National Center for Research and Development

Zitieren

APA

Bartkowiak-Wieczorek, J., Mądry, E., Książkiewicz, M., Winkler-Galicki, J., Szalata, M., Szalata, M., Jiménez, U. E., Wielgus, K., Grześkowiak, E., Słomski, R., & Bienert, A. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. https://doi.org/10.3390/nu15122646

Vancouver

Bartkowiak-Wieczorek J, Mądry E, Książkiewicz M, Winkler-Galicki J, Szalata M, Szalata M, et al. THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. 2023. doi:10.3390/nu15122646

BibTeX
@article{BartkowiakWieczorek2023,
  author = {Bartkowiak-Wieczorek, Joanna and Mądry, Edyta and Książkiewicz, Michał and Winkler-Galicki, Jakub and Szalata, Milena and Szalata, Marlena and Jiménez, Ulises Elizalde and Wielgus, Karolina and Grześkowiak, Edmund and Słomski, Ryszard and Bienert, Agnieszka},
  title = {THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15122646}
}
Kostenlos starten →